Hypertension and diabetes, among other factors, are contributing to skyrocketing rates. Is over-diagnosing and over-treating part of the problem?
Price transparency is a mainstay of most markets. It has been touted as a way to reduce health care spending by enabling a new breed of cost-conscious consumers to comparison shop for care. A new JAMA study suggests that it might not be that simple. Janet Weiner of the Leonard Davis Institute of Health Economics explains.